Cerus Corp. (CERS) Monday announced 15 percent increase in preliminary full year product revenue from the prior year and that exceeded its prior guidance. The company expects 8-11 percent growth in 2025 product revenues.
Full-Year 2024 product revenues is expected to be $180.3 million, while its product revenue guidance was in a range of $177-$179 million. The company said its product revenue growth was driven by sustained momentum across our Intercept platelet franchise.
The 2025 product revenues is projected to be between $194-$200 million, and year-over-year product revenue growth for the first quarter of 2025 is expected to be approximately 10 to 15 percent over the first quarter of 2024.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.